Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease

Journal article

Peer reviewed

G. Alva, J. L. Cummings, J. E. Galvin, X. Meng and D. M. Velting

International journal of clinical practice (Esher), Vol.69(5), pp.518-530

2015-05

PMID: 25684069

Metrics

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.52 Neurodegenerative Diseases; 1.52.60 Dementia
Web Of Science research areas: Pharmacology & Pharmacy
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease
Creators: G. Alva - ATP Clinical Research
J. L. Cummings - Lou Ruvo Brain Institute
J. E. Galvin - NYU Langone Health
X. Meng - Novartis Pharmaceuticals Corporation East Hanover NJ USA.
D. M. Velting - Novartis Pharmaceuticals Corporation East Hanover NJ USA.
Publication Details: International journal of clinical practice (Esher), Vol.69(5), pp.518-530
Publisher: Blackwell Publishing Ltd
Number of pages: 13
Academic Unit: Miller School of Medicine; UMMG Department of Neurology
Language: English
Resource Type: Journal article
PMID: 25684069
Record Identifier: 991031723495502976